Canada Pension Plan Investment Board trimmed its position in shares of NovoCure Limited (NASDAQ:NVCR – Get Rating) by 52.2% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 823 shares of the medical equipment provider’s stock after selling 900 shares during the quarter. Canada Pension Plan Investment Board’s holdings in NovoCure were worth $63,000 at […]
Optune is now available as a treatment for newly diagnosed glioblastoma patients in France Novocure (NASDAQ:NVCR) today announced the reimbursement and availability of Optune together with temozolomide
Pictet Asset Management SA raised its stake in shares of NovoCure Limited (NASDAQ:NVCR – Get Rating) by 1.5% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 39,965 shares of the medical equipment provider’s stock after purchasing an additional 574 shares during the period. Pictet Asset Management […]
Full year 2022 net revenues of $538 million and fourth quarter net revenues of $128 million Pivotal LUNAR study in non-small cell lung cancer met primary overall survival endpoint and a key secondary